Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ATOVAQUONE
- Escalating Monthly Doses of Tafenoquine in Healthy Volunteers
- Atoguanil BA Study
- Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
- Atovaquone for Treatment of COVID-19
- Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
- Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)
- Safety and Efficacy of NF135 CPS Immunization
- Drug Combinations of Atovaquone-Proguanil (AP) With ACT
- Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
- Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2
- Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis
- Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis
- Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1
- Atovaquone as Tumour HypOxia Modifier
- DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria
- The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension
- P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine
- Antiretroviral Drug Interaction Study in Volunteers With HIV
- Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
- Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria
- Weekly Dosing of Malarone ® for Prevention of Malaria
- Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)
- Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials
- Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function
- Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
- Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function
- Chloroquine Alone or in Combination for Malaria in Children in Malawi
- Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
- Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria
- Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
- A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX
- A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole
- A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine
- A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
- An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine
- A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
- A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
- Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
- Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
- A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Clinical trials list
click for details